pehub.com -- Pronota NV, a Belgium-based developer of protein biomarker diagnostics, has raised €4.9 million in the first close of its Series B round. VIB was joined by return backers LSP, Gimv, Biotech Fund Flanders, KBC Private Equity, Johnson & Johnson Development Corporation and Baekeland Fund.
